These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 39076385)

  • 1. Incremental Value of Right Ventricular Outflow Tract Diameter in Risk Assessment of Chronic Heart Failure Patients with Implantable Cardioverter Defibrillators: Development of RVOTD-ICD Benefit Score in Real-World Setting.
    Huang H; Deng Y; Cheng S; Yu Y; Liu X; Niu H; Chen X; Cai C; Gu M; Hua W
    Rev Cardiovasc Med; 2023 Sep; 24(9):269. PubMed ID: 39076385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
    Younis A; Goldberger JJ; Kutyifa V; Zareba W; Polonsky B; Klein H; Aktas MK; Huang D; Daubert J; Estes M; Cannom D; McNitt S; Stein K; Goldenberg I
    Eur Heart J; 2021 May; 42(17):1676-1684. PubMed ID: 33417692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction Efficiency of MADIT-ICD Benefit Score for Outcome in Asian Patients with Implantable Cardioverter-Defibrillator.
    Song K; Hu Y; Chen W; Hua W; Jin Z
    Int J Gen Med; 2022; 15():4409-4416. PubMed ID: 35502185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy.
    Dauw J; Martens P; Nijst P; Meekers E; Deferm S; Gruwez H; Rivero-Ayerza M; Van Herendael H; Pison L; Nuyens D; Dupont M; Mullens W
    Europace; 2022 Sep; 24(8):1276-1283. PubMed ID: 35352116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure.
    Jędrzejczyk-Patej E; Mazurek M; Lazar M; Pruszkowska-Skrzep P; Sokal A; Kowalczyk J; Kowalski O; Kalarus Z; Lenarczyk R
    Kardiol Pol; 2023; 81(10):998-1005. PubMed ID: 37936556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
    Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and Risk of Ventricular Tachyarrhythmia and Death in ICD Recipients.
    Ojo A; McNitt S; Polonsky B; Aktas MK; Rosero S; Hall B; Kutyifa V; Rao N; Rao N; Goldenberg I
    JACC Clin Electrophysiol; 2024 Jul; 10(7 Pt 1):1468-1476. PubMed ID: 38878014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death with an implantable cardioverter-defibrillator: a MADIT-II substudy.
    Chernomordik F; Jons C; Klein HU; Kutyifa V; Nof E; Zareba W; Daubert JP; Greenberg H; Glikson M; Goldenberg I; Beinart R
    Europace; 2019 Dec; 21(12):1843-1850. PubMed ID: 31647531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease.
    Goldenberg I; Kutyifa V; Zareba W; Huang DT; Rosero SZ; Younis A; Schuger C; Gao A; McNitt S; Polonsky B; Steinberg JS; Goldenberg I; Aktas MK
    Front Cardiovasc Med; 2023; 10():1237118. PubMed ID: 37680559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Dhar R; Alsheikh-Ali AA; Estes NA; Moss AJ; Zareba W; Daubert JP; Greenberg H; Case RB; Kent DM
    Heart Rhythm; 2008 Jun; 5(6):807-13. PubMed ID: 18534364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Whether to implant a defibrillator or not? The Possibility of Using the MADIT-ICD Benefit Score Calculator in Real Practice].
    Ilov NN; Boytsov SA; Nechepurenko AA
    Kardiologiia; 2024 Feb; 64(2):27-33. PubMed ID: 38462801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
    Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
    Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.